Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - GLAXOSMITHKLINE PLC (GSK-LN)11$25  View Abstract
12-Apr-14Reuters Investment ProfileN/AGlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
8-Apr-14GlobalDataGlobalDataGlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review86$125  View Abstract
6-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for GlaxoSmithKline plc43$75  View Abstract
24-Mar-14GlobalDataGlobalDataGlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review80$125  View Abstract
20-Mar-14Streetwise ReportsHugh ClelandApply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland10$92  View Abstract
18-Mar-14Harbinger Research LLCBrian R ConnellHarbinger Research Initiates Coverage of Adamis Pharmaceuticals Corp. (ADMP - NasdaqCM) with Strong Buy and $15-$18 price target22$10  View Abstract
12-Mar-14MarketLine (a Datamonitor Company)MarketLineGlaxoSmithKline Plc70$175  View Abstract
6-Mar-14Streetwise ReportsN/ABetter, Faster, Cheaper—You Can Have All Three in Medtech: Ben Haynor7$69  View Abstract
27-Feb-14Streetwise ReportsBryan BrokmeierBryan Brokmeier Remains Bullish on Life Sciences Tools and Diagnostics Companies8$80.50  View Abstract

Independent Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - GLAXOSMITHKLINE PLC (GSK-LN)11$25View Abstract
12-Apr-14Reuters Investment ProfileN/AGlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
8-Apr-14GlobalDataGlobalDataGlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review86$125View Abstract
6-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for GlaxoSmithKline plc43$75View Abstract
24-Mar-14GlobalDataGlobalDataGlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review80$125View Abstract
20-Mar-14Streetwise ReportsHugh ClelandApply Market Savvy to Bear Market Debris; Uncover Biotech Treasures: Cleland and Ireland10$92View Abstract
18-Mar-14Harbinger Research LLCBrian R ConnellHarbinger Research Initiates Coverage of Adamis Pharmaceuticals Corp. (ADMP - NasdaqCM) with Strong Buy and $15-$18 price target22$10View Abstract
12-Mar-14MarketLine (a Datamonitor Company)MarketLineGlaxoSmithKline Plc70$175View Abstract
6-Mar-14Streetwise ReportsN/ABetter, Faster, Cheaper—You Can Have All Three in Medtech: Ben Haynor7$69View Abstract
27-Feb-14Streetwise ReportsBryan BrokmeierBryan Brokmeier Remains Bullish on Life Sciences Tools and Diagnostics Companies8$80.50View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.